Literature DB >> 4967871

A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.

L L Dehnel, N D Vestre, B C Schiele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4967871

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

Review 1.  Zuclopenthixol dihydrochloride for schizophrenia.

Authors:  Edward J Bryan; Marie Ann Purcell; Ajit Kumar
Journal:  Cochrane Database Syst Rev       Date:  2017-11-16

Review 2.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

3.  Placebo response in antipsychotic clinical trials: a meta-analysis.

Authors:  Bret R Rutherford; Emily Pott; Jane M Tandler; Melanie M Wall; Steven P Roose; Jeffrey A Lieberman
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

Review 4.  Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.

Authors:  Kaushadh Jayakody; Roger Carl Gibson; Ajit Kumar; Shalmini Gunadasa
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.